Molecular Biology: Open Access

Shuqi Zhao

Publications

• Research Article
  Nebracetam Inhibited Hippocampus Neurons Injury Induced by Aβ25-35 in MRTF-A-CArG Manner via ERK1/2 Pathway
  Author(s): Tingzi Yin, Xiaolu Cao, Wan Xiao, Ying Zhang, Shuqi Zhao and Xiamin HuTingzi Yin, Xiaolu Cao, Wan Xiao, Ying Zhang, Shuqi Zhao and Xiamin Hu
  
  Nebracetam has been recently proposed to have a neuroprotective action and cognitive enhancing effect being characteristic of a nootropic drug, while the mechanisms remained ambiguity. In this study, we investigated the protective effects of nebracetam on hippocampus neurons injury-induced by β-amyloid protein(Aβ25-35)and its mechanisms. Hippocampus neurons were treated with nebracetam (0.05 mM, 0.2 mM or 0.8 mM) or Aβ25-35 (20 uM/L). We found that Nebracetam significantly reduced apoptotic induced by Aβ25-35 and increase in the total number of dendritic spines and dendritic spine density in a dose-dependent manner. RT-PCR assay and Western blotting analysis revealed that nebracetam increased the expressions of myeloid cell leukemia-1 (Mcl-1), B-cell lymphoma-2 (Bcl-2) and activity regulated cytoskeleton associated protein (Arc) in Aβ25-35-treated hippocampus .. Read More»
  DOI: 10.4172/2168-9547.1000152

  Abstract PDF